Tevogen Bio hosts panel on AI's role in biopharma innovation at J.P. Morgan conference.

Tevogen Bio, a biotech company focused on immunotherapies, will host a panel at the J.P. Morgan Healthcare Conference in San Francisco on January 13, 2025. The panel, titled "AI in Biopharma: Next Frontier of Medical Innovation," will discuss how AI can revolutionize drug discovery, speed up development, enhance patient access, and cut costs. Experts from Tevogen, Microsoft, and Rubix Health will explore AI's role in advancing precision T cell therapies for diseases like cancer and neurological disorders.

3 months ago
4 Articles